Stephens Consulting’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-50
Closed -$375 1290
2025
Q1
$375 Buy
+50
New +$375 ﹤0.01% 1160